Medical cannabinoid firm GW Pharma to be acquired by Jazz Pharmaceuticals for $7.2 billion

MJ DAILY EUROPE

Global pharma company Jazz Pharmaceuticals has reached an agreement to buy U.K.-based GW Pharmaceuticals, one of the largest medical cannabinoid businesses in the world, for $7.2 billion in cash and stock, the drugmakers announced Wednesday. Medical cannabinoid firm GW Pharma to be acquired by Jazz Pharmaceuticals for $7.2 billion is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Excerpt only …
READ MORE BELOW
Source : Medical cannabinoid firm GW Pharma to be acquired by Jazz Pharmaceuticals for .2 billion

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.